CYCS and Parkinson disease: Reduced mitochondrial complex I activity is also reported in PD patients, additionally, the utilization of its inhibitor (e.g., rotenone) is believed to trigger mitochondrial destruction (such as reduced mitochondrial prospects, cytochrome C release, initiation of the caspases, and eventual induction of apoptosis) in exploratory PD models31.